Cerebrospinal Fluid Profile of Lipid Mediators in Alzheimer’s Disease
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cerebrospinal Fluid Profile of Lipid Mediators in Alzheimer’s Disease
Authors
Keywords
-
Journal
CELLULAR AND MOLECULAR NEUROBIOLOGY
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-04-01
DOI
10.1007/s10571-022-01216-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Intranasal delivery of pro-resolving lipid mediators rescues memory and gamma oscillation impairment in AppNL-G-F/NL-G-F mice
- (2022) Ceren Emre et al. Communications Biology
- Receptors for pro‐resolving mediators are increased in Alzheimer's disease brain
- (2020) Ceren Emre et al. BRAIN PATHOLOGY
- N-AS-triggered SPMs are direct regulators of microglia in a model of Alzheimer’s disease
- (2020) Ju Youn Lee et al. Nature Communications
- Carcinogenesis: Failure of resolution of inflammation?
- (2020) Anna Fishbein et al. PHARMACOLOGY & THERAPEUTICS
- Maresin 1 attenuates pro‐inflammatory activation induced by β‐amyloid and stimulates its uptake
- (2020) Ying Wang et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Is Resolution the End of Inflammation?
- (2019) Karen T. Feehan et al. TRENDS IN MOLECULAR MEDICINE
- Preoperative stimulation of resolution and inflammation blockade eradicates micrometastases
- (2019) Dipak Panigrahy et al. JOURNAL OF CLINICAL INVESTIGATION
- Cyclooxygenase-2 Induced the β-Amyloid Protein Deposition and Neuronal Apoptosis Via Upregulating the Synthesis of Prostaglandin E2 and 15-Deoxy-Δ12,14-prostaglandin J2
- (2019) Pei-Pei Guan et al. Neurotherapeutics
- Maresin 1 Improves Cognitive Decline and Ameliorates Inflammation in a Mouse Model of Alzheimer’s Disease
- (2019) Ping Yin et al. Frontiers in Cellular Neuroscience
- NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease
- (2018) Clifford R. Jack et al. Alzheimers & Dementia
- Combined administration of resolvin E1 and lipoxin A4 resolves inflammation in a murine model of Alzheimer's disease
- (2018) Alpdogan Kantarci et al. EXPERIMENTAL NEUROLOGY
- Modulation of Amyloid-β Production by Leukotriene B4 via the γ-Secretase Pathway
- (2018) Yash B. Joshi et al. JOURNAL OF ALZHEIMERS DISEASE
- Restoration of Lipoxin A4 Signaling Reduces Alzheimer's Disease-Like Pathology in the 3xTg-AD Mouse Model
- (2018) Haley C. Dunn et al. JOURNAL OF ALZHEIMERS DISEASE
- Resolvins suppress tumor growth and enhance cancer therapy
- (2017) Megan L. Sulciner et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Diverging longitudinal changes in astrocytosis and amyloid PET in autosomal dominant Alzheimer’s disease
- (2016) Elena Rodriguez-Vieitez et al. BRAIN
- Alzheimer's disease
- (2016) Philip Scheltens et al. LANCET
- CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis
- (2016) Bob Olsson et al. LANCET NEUROLOGY
- Sexually dimorphic brain fatty acid composition in low and high fat diet-fed mice
- (2016) Carlos Rodriguez-Navas et al. Molecular Metabolism
- Resolution of inflammation is altered in Alzheimer's disease
- (2015) Xiuzhe Wang et al. Alzheimers & Dementia
- Neuroinflammation in Alzheimer's disease
- (2015) Michael T Heneka et al. LANCET NEUROLOGY
- Pro-Resolving Lipid Mediators Improve Neuronal Survival and Increase Aβ42 Phagocytosis
- (2015) Mingqin Zhu et al. MOLECULAR NEUROBIOLOGY
- Proresolving Lipid Mediators and Mechanisms in the Resolution of Acute Inflammation
- (2014) Christopher D. Buckley et al. IMMUNITY
- Lipid Mediators in the Resolution of Inflammation
- (2014) Charles N. Serhan et al. Cold Spring Harbor Perspectives in Biology
- The global prevalence of dementia: A systematic review and metaanalysis
- (2013) Martin Prince et al. Alzheimers & Dementia
- Aspirin-Triggered Lipoxin A4 Stimulates Alternative Activation of Microglia and Reduces Alzheimer Disease–Like Pathology in Mice
- (2013) Rodrigo Medeiros et al. AMERICAN JOURNAL OF PATHOLOGY
- Proresolution Lipid Mediators in Multiple Sclerosis — Differential, Disease Severity-Dependent Synthesis — A Clinical Pilot Trial
- (2013) Harald Prüss et al. PLoS One
- The diagnosis of mild cognitive impairment due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease
- (2011) Marilyn S. Albert et al. Alzheimers & Dementia
- Neuroprotectin D1 Induces Neuronal Survival and Downregulation of Amyloidogenic Processing in Alzheimer’s Disease Cellular Models
- (2011) David T. Stark et al. MOLECULAR NEUROBIOLOGY
- Cellular and molecular events mediated by docosahexaenoic acid-derived neuroprotectin D1 signaling in photoreceptor cell survival and brain protection
- (2009) Nicolas G. Bazan PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS
- The pre–mild cognitive impairment, subjective cognitive impairment stage of Alzheimer’s disease
- (2008) Barry Reisberg et al. Alzheimers & Dementia
- Contribution of HLA-DRB1 shared epitope alleles and chronic inflammation to the increased incidence of cardiovascular disease in rheumatoid arthritis: Comment on the article by Farragher et al
- (2008) Miguel A. Gonzalez-Gay et al. ARTHRITIS AND RHEUMATISM
- Cross validation of the Montreal Cognitive Assessment in community dwelling older adults residing in the Southeastern US
- (2008) Cheryl A. Luis et al. INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY
- Diagnosing dementia - ICD-10 not so bad after all: a comparison between dementia criteria according to DSM-IV and ICD-10
- (2007) Mala Naik et al. INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation